Philip Moquist is currently the Director of ADC Chemistry at Pfizer, where they focus on developing payloads and linker technologies for antibody-drug conjugates. With over 15 years of lab experience across academic and industry settings, their background includes synthetic and medicinal chemistry. Philip completed a Bachelor's degree at UC San Diego and a Ph.D. at Boston University, followed by postdoctoral research at the Broad Institute and University of Muenster. Prior to their current role, they held various positions at Kalypsys, Seagen, and Boston University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices